On Aug. 21, 2009, Pamela Plouhar, V.P. for worldwide clinical affairs at DePuy, sent the following e-mail to three company executives. The disclosures in the e-mail contrast with statements made in recent years by the company, which continued to market the device in Europe (and a related model in the United States) before announcing a recall in 2010.
Document: 2009 E-Mail on Recall DePuy Hip Device
Published February 23, 2012 News Leave a CommentTags: DePuy ASR, DePuy ASR hip replacements, DePuy attorney, DePuy complications, DePuy hip implant, DePuy hip replacement, Depuy lawsuit, DePuy lawyer, DePuy letter, DePuy Recall, DePuy warning, FDA letter, FDA warning letter
0 Responses to “Document: 2009 E-Mail on Recall DePuy Hip Device”